2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Short-Acting Insulin Market?

The increasing prevalence of type 1 diabetes is expected to fuel the growth of the short-acting insulin market in the future. Type 1 diabetes is an autoimmune condition where the body destroys insulin-producing cells, requiring lifelong insulin therapy. The rising prevalence of type 1 diabetes is driven by genetic factors, environmental triggers, and increasing autoimmune disorders. Short-acting insulin helps manage type 1 diabetes by providing rapid blood sugar control and mimicking natural insulin response. For example, in 2023, according to Diabetes Australia, an organization focused on raising awareness about diabetes, approximately 134,000 Australians were living with type 1 diabetes in 2022, and this number increased to 135,423 in 2023. Therefore, the growing prevalence of type 1 diabetes is driving the growth of the short-acting insulin market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21287&type=smp

#How Does the ProjectedShort-Acting Insulin Market Growth Compare Over the Forecast Period?

The short-acting insulin market has experienced strong growth, increasing from $11.00 billion in 2024 to $11.65 billion in 2025 at a CAGR of 5.9%. Key drivers include a rising type 1 diabetes population, an aging demographic, increased research and development funding, a growing number of diagnosed cases, and rapid urbanization.

The short-acting insulin market is set to expand significantly, reaching $14.47 billion by 2029 at a CAGR of 5.6%. Growth factors include increased government initiatives, enhanced support for diabetes care, rapid advancements in insulin production, a higher adoption rate of insulin therapy, and the rise of personalized medicine. Key trends shaping the market include innovations in insulin delivery devices, the development of fast-acting insulin analogs, expansion of biosimilar options, a stronger focus on patient-centric diabetes care, and continuous improvements in insulin formulations.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21287

What Are the Key Market Innovations in theShort-Acting Insulin Market Over the Coming Years?

Companies in the short-acting insulin market are developing innovative products like insulin pods to provide continuous insulin infusion for diabetes management. An insulin pod is a tubeless, wearable device that delivers insulin continuously, offering greater convenience and improved adherence. For example, in April 2023, Insulet Corporation received FDA clearance for its Omnipod GO, a basal-only insulin pod designed for adults with type 2 diabetes. This device eliminates the need for daily injections, providing pre-programmed insulin rates and enhancing patient convenience.

Who Are the Top Companies Driving Innovation and Growth in theShort-Acting Insulin Market?

Major companies operating in the short-acting insulin market are Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Baxter International Inc., Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Biocon Limited, Kissei Pharmaceutical Co. Ltd., Lupin Limited, Wockhardt Ltd., Lannett Co. Inc., MannKind Corporation, Sihuan Pharmaceutical Holdings Group Ltd., Julphar(Gulf Pharmaceutical Industries), Geropharm LLC, Bioton S.A., hec pharm co. ltd, ADOCIA SAS, Gan & Lee Pharmaceuticals Co. Ltd., Adocia S.A.S.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/short-acting-insulin-global-market-report

Which Key Market Segments Comprise the Short-Acting Insulin Market and Drive Its Revenue Growth?

The short-acting insulin market covered in this report is segmented –

1) By Formulation: Regular Insulin, Rapid-Acting Insulin

2) By Dosage Form: Vials, Pre-filled Pens, Cartridges

3) By Route Of Administration: Subcutaneous, Intravenous

4) By Patient Type: Type 1 Diabetes, Type 2 Diabetes

5) By Distribution Channel: Pharmacies, Hospital Pharmacies, Online Pharmacies

Subsegments:

1) By Regular Insulin: Human Regular Insulin, Animal-Derived Regular Insulin, Other Regular Insulin

2) By Rapid-Acting Insulin: Insulin Lispro, Insulin Aspart, Insulin Glulisine

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21287&type=smp

Which Regions Are Emerging as Leaders in the Short-Acting Insulin Market?

North America was the largest region in the short-acting insulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short-acting insulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Short-Acting Insulin Market 2025, By The Business Research Company:

Venous Thromboembolism Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report

Thrombophilia Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report

Deep Vein Thrombosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: